InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Whitehawk Therapeutics, Inc.

WHWK Clue Score25
United States Fiscal year ends December CIK 0001422142 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

132
Insider
Date
Role
Action
Shares
Price
Amount
Scott M. Giacobello
16 Apr 2026
Chief Financial Officer
Sell
141,600
$4.13
$584.81K
Scott M. Giacobello
15 Apr 2026
Chief Financial Officer
Sell
77,000
$3.86
$297.22K
Bryan Ball
14 Apr 2026
See remarks
Sell
92,460
$3.64
$336.55K
Bryan Ball
13 Apr 2026
See remarks
Sell
26,389
$3.46
$91.31K
Bryan Ball
10 Apr 2026
See remarks
Sell
6,596
$3.43
$22.62K
David James Lennon
9 Apr 2026
Chief Executive Officer
Sell
14,500
$3.38
$49.01K
Bryan Ball
9 Apr 2026
See remarks
Sell
50,000
$3.57
$178.50K
David James Lennon
8 Apr 2026
Chief Executive Officer
Sell
63,945
$3.40
$217.41K
David James Lennon
7 Apr 2026
Chief Executive Officer
Sell
94,087
$3.43
$322.72K
David James Lennon
6 Apr 2026
Chief Executive Officer
Sell
102,395
$3.51
$359.41K
David James Lennon
2 Apr 2026
Chief Executive Officer
Sell
26,858
$3.48
$93.47K
Bryan Ball
2 Mar 2026
See remarks
Sell
1,834
$3.31
$6.07K
Scott M. Giacobello
2 Mar 2026
Chief Financial Officer
Sell
2,594
$3.31
$8.59K
David James Lennon
2 Mar 2026
Chief Executive Officer
Sell
5,100
$3.31
$16.88K
David James Lennon
3 Mar 2025
Chief Executive Officer
Sell
5,690
$2.35
$13.37K
Scott M. Giacobello
3 Mar 2025
Chief Financial Officer
Sell
2,806
$2.35
$6.59K
Bryan Ball
3 Mar 2025
See remarks
Sell
2,147
$2.35
$5.05K
David James Lennon
3 Oct 2024
Chief Executive Officer
Sell
9,689
$1.94
$18.80K
Neil Desai
3 Sep 2024
Executive Chairman
Sell indirect
40,000
$1.71
$68.32K
Neil Desai
5 Aug 2024
Executive Chairman
Sell indirect
5,652
$1.34
$7.59K
Neil Desai
2 Aug 2024
Executive Chairman
Sell indirect
18,933
$1.41
$26.70K
Neil Desai
1 Aug 2024
Executive Chairman
Sell indirect
15,415
$1.50
$23.05K
Neil Desai
2 Jul 2024
Executive Chairman
Sell indirect
8,652
$1.34
$11.61K
Neil Desai
1 Jul 2024
Executive Chairman
Sell indirect
31,348
$1.45
$45.61K
Neil Desai
4 Jun 2024
Executive Chairman
Sell indirect
20,225
$1.77
$35.75K
Neil Desai
3 Jun 2024
Executive Chairman
Sell indirect
19,775
$1.81
$35.77K
Neil Desai
1 May 2024
Executive Chairman
Sell indirect
40,000
$1.93
$77.18K
Neil Desai
2 Apr 2024
Executive Chairman
Sell indirect
22,228
$2.23
$49.51K
Neil Desai
1 Apr 2024
Executive Chairman
Sell indirect
17,772
$2.31
$41.10K
Neil Desai
4 Mar 2024
Executive Chairman
Sell indirect
14,964
$2.10
$31.42K
Neil Desai
1 Mar 2024
Executive Chairman
Sell indirect
27,036
$1.97
$53.23K
Neil Desai
1 Feb 2024
Executive Chairman
Sold on a plan indirect
42,000
$1.74
$73.27K
Neil Desai
2 Jan 2024
Executive Chairman
Sell indirect
42,000
$2.06
$86.55K
Neil Desai
6 Dec 2023
Executive Chairman
Sell indirect
7,037
$4.82
$33.91K
Neil Desai
5 Dec 2023
Executive Chairman
Sell indirect
15,740
$5.02
$78.94K
Neil Desai
4 Dec 2023
Executive Chairman
Sell indirect
10,876
$5.15
$55.99K
Neil Desai
1 Dec 2023
Executive Chairman
Sell indirect
8,347
$5.14
$42.88K
Neil Desai
2 Nov 2023
Executive Chairman
Sell indirect
31,662
$4.46
$141.10K
Neil Desai
1 Nov 2023
Executive Chairman
Sell indirect
10,338
$4.32
$44.64K
Neil Desai
3 Oct 2023
Executive Chairman
Sell indirect
16,431
$4.10
$67.30K
Neil Desai
2 Oct 2023
Executive Chairman
Sell indirect
25,569
$4.37
$111.70K
Neil Desai
6 Sep 2023
Executive Chairman
Sell indirect
7,111
$5.29
$37.64K
Neil Desai
5 Sep 2023
Executive Chairman
Sell indirect
21,000
$5.63
$118.32K
Neil Desai
1 Sep 2023
Executive Chairman
Sell indirect
13,889
$5.97
$82.87K
Neil Desai
2 Aug 2023
Executive Chairman
Sell indirect
19,290
$5.20
$100.25K
Neil Desai
1 Aug 2023
Executive Chairman
Sell indirect
22,710
$5.22
$118.52K
Neil Desai
6 Jul 2023
Executive Chairman
Sell indirect
15,829
$6.27
$99.27K
Neil Desai
5 Jul 2023
Executive Chairman
Sell indirect
16,171
$6.55
$105.87K
Neil Desai
3 Jul 2023
Executive Chairman
Sell indirect
10,000
$6.64
$66.45K
Neil Desai
6 Jun 2023
Executive Chairman
Sell indirect
7,260
$8.19
$59.45K
Neil Desai
5 Jun 2023
Executive Chairman
Sell indirect
17,315
$8.11
$140.42K
Neil Desai
2 Jun 2023
Executive Chairman
Sell indirect
12,443
$7.99
$99.42K
Neil Desai
1 Jun 2023
Executive Chairman
Sell indirect
4,982
$7.92
$39.47K
Neil Desai
4 May 2023
Executive Chairman
Sell indirect
2,305
$7.57
$17.44K
Neil Desai
3 May 2023
Executive Chairman
Sell indirect
7,695
$7.68
$59.07K
Neil Desai
2 May 2023
Executive Chairman
Sell indirect
7,521
$7.48
$56.22K
Neil Desai
1 May 2023
Executive Chairman
Sell indirect
24,479
$7.80
$190.89K
Neil Desai
6 Apr 2023
Executive Chairman
Sell indirect
12,212
$7.09
$86.62K
Neil Desai
5 Apr 2023
Executive Chairman
Sell indirect
7,336
$7.24
$53.08K
Neil Desai
4 Apr 2023
Executive Chairman
Sell indirect
12,869
$7.30
$93.98K
Neil Desai
3 Apr 2023
Executive Chairman
Sell indirect
9,583
$7.45
$71.36K
Neil Desai
18 Mar 2022
See Remarks
Sell indirect
3,550
$20.07
$71.23K
Anupam Dalal
26 Aug 2021
Director
Buy indirect
1,529,402
$13.08
left out
Caley Castelein
26 Aug 2021
Director
Buy indirect
259,998
$13.08
left out
Orbimed Advisors LLC
8 Dec 2020
10% owner
Sold after exercise indirect
21,400
$1.96
$41.94K
Joseph H. Gardner
10 Jul 2019
President
Buy
5,000
$0.81
$4.07K
Joseph H. Gardner
3 Jul 2019
President
Buy
5,000
$0.90
$4.49K
Novartis Bioventures Ltd
26 Apr 2019
10% owner
Sell indirect
138,704
$1.03
$142.87K
Novartis Bioventures Ltd
25 Apr 2019
10% owner
Sell indirect
563,096
$1.03
$579.99K
Novartis Bioventures Ltd
24 Apr 2019
10% owner
Sell indirect
16,403
$1.03
$16.90K
Novartis Bioventures Ltd
23 Apr 2019
10% owner
Sell indirect
27,554
$1.03
$28.38K
Novartis Bioventures Ltd
22 Apr 2019
10% owner
Sell indirect
7,100
$0.97
$6.89K
Novartis Bioventures Ltd
15 Apr 2019
10% owner
Sell indirect
28,794
$0.99
$28.51K
Novartis Bioventures Ltd
12 Apr 2019
10% owner
Sell indirect
30,908
$1.04
$32.14K
Novartis Bioventures Ltd
11 Apr 2019
10% owner
Sell indirect
57,438
$1.08
$62.03K
Novartis Bioventures Ltd
10 Apr 2019
10% owner
Sell indirect
140,230
$1.09
$152.85K
Novartis Bioventures Ltd
9 Apr 2019
10% owner
Sell indirect
32,991
$1.01
$33.32K
Novartis Bioventures Ltd
8 Apr 2019
10% owner
Sell indirect
27,525
$1.02
$28.08K
Novartis Bioventures Ltd
5 Apr 2019
10% owner
Sell indirect
24,661
$1.02
$25.15K
Novartis Bioventures Ltd
4 Apr 2019
10% owner
Sell indirect
47,900
$1.01
$48.38K
Novartis Bioventures Ltd
3 Apr 2019
10% owner
Sell indirect
58,033
$0.96
$55.71K
Novartis Bioventures Ltd
2 Apr 2019
10% owner
Sell indirect
51,754
$0.97
$50.20K
Novartis Bioventures Ltd
1 Apr 2019
10% owner
Sell indirect
116,909
$0.95
$111.06K
Novartis Bioventures Ltd
29 Mar 2019
10% owner
Sell indirect
63,100
$0.91
$57.42K
Novartis Bioventures Ltd
28 Mar 2019
10% owner
Sell indirect
88,835
$0.94
$83.50K
Novartis Bioventures Ltd
27 Mar 2019
10% owner
Sell indirect
50,749
$0.99
$50.24K
Novartis Bioventures Ltd
26 Mar 2019
10% owner
Sell indirect
177,762
$1.01
$179.54K
Muneer A Satter
10 Jan 2019
Director
Buy indirect
23,818
$2.45
$58.44K
Muneer A Satter
9 Jan 2019
Director
Buy indirect
20,000
$2.39
$47.88K
Muneer A Satter
8 Jan 2019
Director
Buy indirect
20,000
$2.20
$43.97K
Muneer A Satter
7 Jan 2019
Director
Buy indirect
20,000
$2.18
$43.56K
Muneer A Satter
4 Jan 2019
Director
Buy indirect
20,000
$2.12
$42.40K
Muneer A Satter
3 Jan 2019
Director
Buy indirect
20,000
$2.08
$41.51K
Muneer A Satter
2 Jan 2019
Director
Buy indirect
20,000
$1.94
$38.84K
Muneer A Satter
31 Dec 2018
Director
Buy indirect
20,000
$1.75
$34.90K
Muneer A Satter
28 Dec 2018
Director
Buy indirect
20,000
$1.72
$34.37K
Muneer A Satter
27 Dec 2018
Director
Buy indirect
20,000
$1.67
$33.41K
Muneer A Satter
26 Dec 2018
Director
Buy indirect
20,000
$1.69
$33.85K
Muneer A Satter
21 Dec 2018
Director
Buy indirect
20,000
$1.84
$36.87K
Muneer A Satter
20 Dec 2018
Director
Buy indirect
20,000
$1.85
$36.98K
Muneer A Satter
19 Dec 2018
Director
Buy indirect
20,000
$1.92
$38.38K
Muneer A Satter
18 Dec 2018
Director
Buy indirect
20,000
$1.99
$39.86K
Muneer A Satter
14 Dec 2018
Director
Buy indirect
20,000
$2.00
$40.09K
Muneer A Satter
13 Dec 2018
Director
Buy indirect
20,000
$2.02
$40.31K
Muneer A Satter
12 Dec 2018
Director
Buy indirect
20,000
$2.05
$40.94K
Muneer A Satter
11 Dec 2018
Director
Buy indirect
20,000
$2.09
$41.85K
Muneer A Satter
10 Dec 2018
Director
Buy indirect
20,000
$2.13
$42.61K
Muneer A Satter
7 Dec 2018
Director
Buy indirect
20,000
$2.14
$42.79K
Muneer A Satter
6 Dec 2018
Director
Buy indirect
20,000
$2.18
$43.58K
Muneer A Satter
4 Dec 2018
Director
Buy indirect
20,000
$2.10
$41.99K
Muneer A Satter
3 Dec 2018
Director
Buy indirect
20,000
$1.99
$39.77K
Muneer A Satter
30 Nov 2018
Director
Buy indirect
20,000
$1.98
$39.69K
Muneer A Satter
29 Nov 2018
Director
Buy indirect
20,000
$2.01
$40.12K
Muneer A Satter
28 Nov 2018
Director
Buy indirect
20,000
$1.94
$38.71K
Stephen J Hoffman
12 Nov 2018
Chief Executive Officer
Buy
30,000
$2.01
$60.30K
Stephen J Hoffman
9 Nov 2018
Chief Executive Officer
Buy
1,967
$1.95
$3.84K
Novartis Bioventures Ltd
20 Aug 2018
10% owner
Sell indirect
5,300
$3.90
$20.67K
Muneer A Satter
28 Jun 2018
Director
Buy indirect
1,818,182
$3.85
$7.00M
Chau Quang Khuong
28 Jun 2018
Director
Buy indirect
777,500
$3.85
$2.99M
Orbimed Advisors LLC
28 Jun 2018
Director
Buy indirect
777,500
$3.85
$2.99M
Muneer A Satter
23 Mar 2018
Director
Buy indirect
1,000
$5.00
$5.00K
Muneer A Satter
21 Mar 2018
Director
Buy indirect
4,000
$4.85
$19.39K
Muneer A Satter
20 Mar 2018
Director
Buy indirect
5,400
$4.97
$26.86K
Muneer A Satter
19 Mar 2018
Director
Buy indirect
7,600
$4.96
$37.72K
Muneer A Satter
15 Mar 2017
Director
Buy indirect
1,120,000
$5.00
$5.60M
Novartis Bioventures Ltd
15 Mar 2017
10% owner
Buy indirect
560,000
$5.00
$2.80M
Paul M Weiss
15 Mar 2017
Director
Buy indirect
272,302
$5.00
$1.36M
Joseph H. Gardner
15 Mar 2017
See Remarks
Buy
99,996
$5.00
$499.98K
Orbimed Advisors LLC
15 Mar 2017
Director
Buy indirect
762,995
$5.00
$3.81M
Kevin G. Peters
15 Mar 2017
Chief Scientific Officer
Buy
3,642
$5.00
$18.21K
Chau Quang Khuong
15 Mar 2017
Director
Buy indirect
762,995
$5.00
$3.81M
Caley Castelein
15 Mar 2017
Director
Buy indirect
400,000
$5.00
$2.00M

What was left out

Form 4 filings counted 217
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 21
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 1
Sales at will 82
Transactions with no price 2
Shares from compensation/vesting 13,720,945
Sales filed before the plan box existed 22
History held since 17 Mar 2017